EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 7,330.00
-20.00 (-0.27%)
At close: Feb 27, 2026
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 242.49 billion as of February 27, 2026. Its market cap has increased by 43.77% in one year.
Market Cap
242.49B
Enterprise Value
379.30B
Revenue
465.24B
Ranking
n/a
PE Ratio
11.03
Stock Price
7,330.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 242.49B, an increase of 597.66%. That is a compound annual growth rate of 40.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 242.49B | 26.16% |
| Dec 30, 2025 | 192.21B | 37.78% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 368.16B |
| JETEMA, | 367.28B |
| Anterogen.Co.,Ltd. | 359.72B |
| Bioneer | 320.31B |
| Helixmith | 300.23B |
| HLB Therapeutics | 228.36B |
| Vaxcell-Bio Therapeutics | 215.83B |
| Genexine | 201.70B |